ENTITY

Nektar Therapeutics (NKTR US)

8

Analysis

Health Care • United States

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

more

Refresh

03 Jun 2023 00:05

Current report pursuant to Section 13 or 15(d) (PDF)

Exchange Announcement

Share

18 May 2023 04:29

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

18 May 2023 04:28

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

18 May 2023 04:27

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

10 May 2023 00:20

Current report pursuant to Section 13 or 15(d) (PDF)

Exchange Announcement

Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.12.3

x